𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma

✍ Scribed by Brandi M. Kenner-Bell; Amy S. Paller; Mario E. Lacouture


Book ID
116585979
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
303 KB
Volume
63
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Targeting the epidermal growth factor re
✍ Andreas P. Sutter; Michael HΓΆpfner; Alexander Huether; Kerstin Maaser; Hans Sche πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 370 KB πŸ‘ 1 views

## Abstract Esophageal cancer is the sixth most common cause of cancer‐related death worldwide. Because of very poor 5‐year survival new therapeutic approaches are mandatory. Erlotinib (Tarcevaβ„’), an inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR‐TK), potently suppresses the gr